共 9 条
[5]
GILLETTE JR, 1975, CONCEPTS BIOCH PHA 3, P35
[6]
Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688
[7]
Pang K S, 1977, J Pharmacokinet Biopharm, V5, P655, DOI 10.1007/BF01059689
[8]
HEPATIC CLEARANCE OF DRUGS .3. ADDITIONAL EXPERIMENTAL-EVIDENCE SUPPORTING WELL-STIRRED MODEL, USING METABOLITE (MEGX) GENERATED FROM LIDOCAINE UNDER VARYING HEPATIC BLOOD-FLOW RATES AND LINEAR CONDITIONS IN PERFUSED RAT-LIVER INSITU PREPARATION
[J].
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS,
1977, 5 (06)
:681-699
[9]
WILKINSON GR, 1976, EFFECT DISEASE STATE, P13